Table 4 Change in bone mineral density (BMD) and Z-scores from baseline to 4 years for all patients who at the 2-year control point were either in remission or not, and separately for the two treatment groups

	All patients (n = 150)			Prednisolone group (n = 64)			No prednisolone group (n = 86)
	In remission	No remission	p Value	In remission	No remission	p Value	In remission	No remission	p Value
L2–L4
BMD change 0–4 years	−0.01 (0.07)	−0.02 (0.08)	0.46	−0.01 (0.07)	−0.03 (0.07)	0.29	0.003 (0.05)	−0.007 (0.08)	0.62
Z-score change 0–4 years	−0.03 (0.55)	−0.09 (0.79)	0.62	−0.13 (0.57)	−0.24 (0.65)	0.48	0.10 (0.5)	−0.01 (0.85)	0.56
Femur neck
BMD change 0–4 years	−0.04 (0.06)	−0.03 (0.06)	0.56	−0.03 (0.06)	−0.04 (0.06)	0.85	−0.05 (0.07)	−0.03 (0.05)	0.29
Z-score change 0–4 years	−0.26 (0.52)	−0.10 (0.49)	0.07	−0.23 (0.45)	−0.16 (0.50)	0.62	−0.31 (0.62)	−0.06 (0.49)	0.07

Values are mean (SD). p Values are between patients in remission versus not in remission.